GSA Sets Focus on Optimizing Older Adults’ Pain Care

 

Washington, DC (September 15, 2011) – To highlight Pain Awareness Month in September, The Gerontological Society of America (GSA) — the nation’s largest interdisciplinary organization devoted to the field of aging — is announcing two forthcoming publications focused on pain relief and medication for seniors.

 

Paired with its other recent research findings, GSA aims to provide readers with information on how new advances in pain prevention, treatment, and management may improve care and quality of life for older adults.

Both new publications are part of GSA’s From Publication to Practice series, which aims to promote the translation of research into meaningful health outcomes. They are slated to be released in November 2011.

One of the installments, “An Interdisciplinary Look at Advancing Pain Research, Care, and Education,” will be supported by Purdue Pharma, L.P. It will address shortfalls in pain assessment and treatment for older adults with pain. This resource largely will be based on a recent Institute of Medicine report, “Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.”

The other new issue, “An Interdisciplinary Look at Labeling Changes for Acetaminophen and the Implications for Patient Care,” will be supported by McNeil Consumer Healthcare. In response to several recent significant modifications to the recommended dosage for acetaminophen, it is being produced in order to ensure that clinicians and aging network professionals are aware of these developments and the subsequent implications for patient care.

These publications join a collection of research that GSA has published within the last year on the subject of pain.

For example, the latest edition of the organization’s WHAT’S HOT newsletter demonstrated that improved management of chronic pain can significantly reduce disability in older adults. This issue examines the impact of pain in older adults, strategies for managing pain and preserving function, and methods to improve the assessment and management of pain for residents in long-term care facilities, including those who have dementia. The newsletter points out that pain is a signal that something is wrong, and that reports of pain should not be dismissed simply because the patient is older.

Furthermore, a January 2011 article in the Journals of Gerontology Series A: Biological Sciences and Medical Sciences points out that musculoskeletal pain is associated increased mobility disability in older people. A September 2010 study in the same journal found that seniors with moderate to severe musculoskeletal pain had more than twice the risk for impaired balance compared with those without pain.

 

 

The Gerontological Society of America (GSA) is the nation’s oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging. The principal mission of the Society — and its 5,400+ members — is to advance the study of aging and disseminate information among scientists, decision makers, and the general public. GSA’s structure also includes a policy institute, the National Academy on an Aging Society, and an educational branch, the Association for Gerontology in Higher Education.

 


 

The Gerontological Society of America (GSA), 15.09.2011 (tB).

MEDICAL NEWS

COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…
Suliqua®: In komplexem Umfeld – einfach besser eingestellt
Suliqua®: Überlegene HbA1c-Senkung  im Vergleich zu Mischinsulinanalogon
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 

ERNÄHRUNG

Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen

ONKOLOGIE

Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
WHO veröffentlicht erste Klassifikation von Tumoren im Kindesalter
Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!

MULTIPLE SKLEROSE

Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…
Stellungnahme zur 3. Impfung gegen SARS-CoV2 bei Personen mit MS
NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…